| Current Price | $4.02 | Mkt Cap | $2.7B |
|---|---|---|---|
| Open | $3.96 | P/E Ratio | 0.00 |
| Prev. Close | $4.02 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.91 - $4.14 | Volume | 9,560,052 |
| 52-Wk Range | $1.12 - $4.27 | Avg. Daily Vol. | 14,389,348 |
| Current Price | $4.02 | Mkt Cap | $2.7B |
|---|---|---|---|
| Open | $3.96 | P/E Ratio | 0.00 |
| Prev. Close | $4.02 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.91 - $4.14 | Volume | 9,560,052 |
| 52-Wk Range | $1.12 - $4.27 | Avg. Daily Vol. | 14,389,348 |
The best Bull and Bear pitches based on recency and number of recommendations.
Their 4KScore Test accurately predicts prostate cancer risk has received insurance classificationTheir drug Rayaldee with a +$10B market potential completed phase 3 trials and an NDA was submitted to to the FDA last May we approval expect in… More
Uses known stock promoter Redchip.com. Is a pump and dump scam.
Read the most recent pitches from players about OPK.
Recs
Paco57
(61.97)
Submitted: 7/6/2020 7:18:09 PM :
Start Price:
$3.69
NASDAQ:OPK Score:
+8.19
Looking pretty Good!
Recs
TMFSaintCroix
(99.80)
Submitted: 3/6/2020 4:29:10 PM :
Start Price:
$2.40
NASDAQ:OPK Score:
+58.32
I'm buying Opko Health as part of a Covid-19 basket. My other two stocks in this area are Novavax and Altimmune. Opko is one of the largest diagnostic companies in the US, and they are introducing a diagnostic test for Covid-19 next week. Unlike Novavax and Altimmune, who are biotechs doing research into vaccines for Covid-19 (and the flu), Opko's diagnostic will be approved right away, and they can start getting revenues very quickly. Congress just approved $8.3 billion in emergency spending for Covid-19, so I assume some of that money will be heading Opko's way. Outperform.
Recs
TMFBiologyFool
(71.12)
Submitted: 7/12/2018 5:30:48 PM :
Start Price:
$6.23
NASDAQ:OPK Score:
+49.32
Up substantially on no apparent news.
Find the members with the highest scoring picks in OPK.
romanson3625 (< 20) Score: +236.00
The Score Leader is the player with the highest score across all their picks in OPK.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| stereotyp72 | 64.90 | 11/5/2019 |
|
5Y | $1.52 | +164.47% | +3.33% | +161.14 | 0 Comment | |
|
superdealsonly | 35.45 | 2/4/2013 |
|
5Y | $6.81 | -40.97% | +111.43% | +152.40 | 0 Comment |
| MisterCHW | 99.88 | 1/29/2013 |
|
5Y | $6.80 | -40.88% | +111.09% | +151.97 | 0 Comment | |
| iniesta13 | < 20 | 3/25/2013 |
|
1Y | $7.61 | -47.17% | +103.72% | +150.89 | 0 Comment | |
| tortoisetriguy | 42.01 | 2/14/2013 |
|
5Y | $6.83 | -41.14% | +109.52% | +150.66 | 0 Comment | |
| XMFConnor | 94.38 | 5/16/2012 |
|
5Y | $4.62 | -12.99% | +137.29% | +150.27 | 0 Comment | |
| Covestor | 75.68 | 3/14/2011 |
|
NS | $3.76 | +6.91% | +144.95% | +138.03 | 1 Comment | |
| Quaker08 | 24.19 | 12/12/2013 |
|
5Y | $9.74 | -58.71% | +78.41% | +137.12 | 0 Comment | |
| stratisticalarb | 59.59 | 4/26/2011 |
|
1Y | $3.99 | +0.74% | +135.84% | +135.10 | 0 Comment | |
| eagles777 | 65.18 |
|
|
NS | $1.64 | +145.87% | +13.97% | +131.90 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
